Interest of the dosage of Bet v 1 recombinant allergen specific IgEs to assess the responsibility of spring pollinosis;Intérêt du dosage des IgE vis-à-vis de l'allergène recombinant rBet v 1 dans la prise en charge de la pollinose printanière

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 45, Issue 8, 2005, Pages 584-589

  Metz Favre, C ^a   Birba, E ^a   Metivier, A C ^a   De Blay, F ^a   Pauli, G ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Bet v 1; Bet v 2; Bet v 3; Birch pollinosis; Diagnosis; Recombinant allergen

Indexed keywords

IMMUNOGLOBULIN E; POLLEN EXTRACT; RECOMBINANT BET V 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTHMA; BIRCH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLLEN ALLERGY; PREDICTION; SENSITIVITY AND SPECIFICITY; SKIN TEST; SYMPTOMATOLOGY;

EID: 29244464756     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.allerg.2005.09.007     Document Type: Article

References (21)

1. G. Pauli, J.P. Oster, P. Deviller, S. Heiss, J.C. Bessot, and M. Susani Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: diagnostic value for birch pollen and associated allergies J. Allergy Clin. Immunol. 97 1996 1100 1109
2. G. Menz, C. Dolecek, U. Schönheit-Kenn, F. Ferreira, M. Moser, and T. Schneider Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v 1, the major birch pollen allergen Clin. Exp. Allergy 26 1996 50 60
3. J. Godnic-Cvar, M. Susani, H. Breiteneder, A. Berger, L. Havelec, and T. Waldhör Recombinant Bet v 1, the major birch pollen allergen, induces hypersensitivity reactions equal to those induced by natural Bet v 1 in the airways of patients allergic to tree pollen J. Allergy Clin. Immunol. 99 1997 354 359
4. S. Tresch, D. Holzmann, S. Baumann, K. Blaser, B. Wüthrich, and R. Crameri In vitro and in vivo allergenicity of recombinant Bet v 1 compared to the reactivity of natural birch pollen extract Clin. Exp. Allergy 33 2003 1153 1158
5. R. Valenta, M. Duchene, S. Vrtala, T. Birkner, C. Ebner, and R. Hirschwehr Recombinant allergens for immunoblot diagnosis of tree-pollen allergy J. Allergy Clin. Immunol. 88 1991 889 894
6. R.E. Rossi, G. Monasterolo, D. Operti, and M. Corsi Evaluation of recombinant allergens Bet v 1 and Bet v 2 (profilin) by Pharmacia CAP System in patients with pollen-related allergy to birch and apple Allergy 51 1996 940 945
7. R. Valenta, W.R. Sperr, F. Ferreira, P. Valent, C. Sillaber, and M. Tejkl Induction of specific histamine release from basophils with purified natural and recombinant birch pollen allergens J. Allergy Clin. Immunol. 91 1993 88 97
8. S. Heiss, V. Mahler, R. Steiner, S. Spitzauer, C. Schweiger, and D. Kraft Component-resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing J. Invest. Dermatol. 113 1999 830 837
9. R. Moverare, K. Westritschnig, M. Svensson, B. Hayek, M. Bende, and G. Pauli Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization Int. Arch. Allergy Immunol. 128 2002 325 335
10. L. Elfman, M. Svensson, J. Lidholm, G. Pauli, and R. Valenta Different profiles in specific IgE to rBet v 1 and rBet v 2 in patients allergic to birch pollen from six countries Int. Arch. Allergy Immunol. 113 1997 249 251
11. A. Mari, M. Wallner, and F. Ferreira Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4) Clin. Exp. Allergy 33 2003 1419 1428
12. R.E. Rossi, G. Monasterolo, and S. Monasterolo Detection of specific IgE antobidies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles Allergy 58 2003 929 932
13. N. Mothes, F. Horak, and R. Valenta Transition from a botanical to a molecular classification in tree pollen allergy: implications for diagnosis and therapy Int. Arch. Allergy Immunol. 135 2004 357 373
14. M. van Hage-Hamsten, E. Johansson, A. Roquet, C. Peterson, M. Andersson, and L. Greiff Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis Clin. Exp. Allergy 32 2002 1448 1453
15. J.C. Bessot, A. Dietemann-Molard, P.A. Braun, and G. Pauli Les associations de pollinose aux b́tulaćes et d'allergie alimentaire aux pommes et autres v́ǵtaux Rev. Fr. Allergol. 24 1984 29 33
16. C. Anhoj, V. Backer, and H. Nolte Diagnostic evaluation of grass- and birch-allergic patients with oral allergy syndrome Allergy 56 2001 548 552
17. F. Karamloo, A. Wangorsch, H. Kasahara, L.B. Davin, D. Haustein, and N.G. Lewis Phenylcoumaran benzylic ether and isoflavonoid reductases are a new class of cross-reactive allergens in birch pollen, fruits and vegetables Eur. J. Biochem. 268 2001 5310 5320
18. H. Malandain, and F. Lavaud Allerǵnicit́ des prot́ines de d́fense v́ǵtale Rev. Fr. Allergol. Immunol. Clin. 44 2004 469 475
19. R. Asero, G. Mistrello, D. Roncarolo, S. Amato, D. Zanoni, and F. Barocci Detection of clinical markers of sensitization to profilin in patients allergic to plan-derived foods J. Allergy Clin. Immunol. 112 2003 427 432
20. M. Wensing, J.H. Akkerdaas, A. van Leeuwen, S.O. Stapel, C.A.F.M. Bruijnzeel-Koomen, and R.C. Aalberse IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance J. Allergy Clin. Immunol. 110 2002 435 442
21. A. Purohit, S. Laffer, C. Metz-Favre, A. V́rot, F. Kricek, and R. Valenta Poor association between allergen-specific serum immunoglobulin E levels, skin sensitivity and basophil degranulation: a study with recombinant birch pollen allergen Bet v 1 and an immunoglobulin E detection system measuring immunoglobulin E capable of binding to FcεRI Clin. Exp. Allergy 35 2005 186 192